4
Changes in Ownership
TScan Therapeutics, Inc. Filed Acc 0000899243-21-037147
Chief Scientific Officer bought 5,000 shares at an average $6.22 ($31,097)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MacBeath Gavin Chief Scientific Officer | 2021-09-20 | Purchase | +4,943 | $6.22 | $30,744 | 49,710 | D |
| MacBeath Gavin Chief Scientific Officer | 2021-09-21 | Purchase | +57 | $6.19 | $353 | 49,767 | D |
| Open-market purchases · 5,000 sh · avg $6.22 · $31,097 | |||||||
Loading xslF345X03/doc4.xml…